Speaker illustration

Doctor Max Waters

University Hospital Limerick, Limerick (Ireland)

Member of:

European Society of Cardiology

Expected eligibility for PCSK9i therapy in secondary prevention, ESC/EAS guidelines vs Irish reimbursement criteria in post PCI patients

Event: ESC Congress 2023

Topic: Drug therapy

Session: Risk factors and prevention: lipids (3)

Thumbnail

Cost impact of the ESC/EAS 2019 dyslipidemia guidelines recommended use of PSCK9i in very-high-risk patients with an LDL <1.8mmol/L for secondary prevention

Event: ESC Congress 2023

Topic: Drug therapy

Session: Risk factors and prevention: lipids (2)

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb